Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies

Tadeja Kuret, Blaž Burja, Julia Feichtinger, Gerhard G Thallinger, Mojca Frank-Bertoncelj, Katja Lakota, Polona Žigon, Snezna Sodin-Semrl, Saša Čučnik, Matija Tomšič, Alojzija Hočevar

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Giant cell arteritis (GCA) is a systemic vasculitis in individuals older than 50 years, characterized by headaches, visual disturbances, painful scalp, jaw claudication, impairment of limb arteries, and systemic inflammation, among other symptoms. GCA diagnosis is confirmed by a positive temporal artery biopsy (TAB) or by imaging modalities. A prominent acute phase response with inflammation is the hallmark of the disease, predominantly targeting large- and medium-sized arteries leading to stenosis or occlusion of arterial lumen. To date, there are no reliable tissue markers specific for GCA. Scarce reports have indicated the importance of epigenetics in GCA. The current systematic review reports significantly changed candidate biomarkers in TABs of GCA patients compared to non-GCA patients using qPCR.

Original languageEnglish
JournalClinical Rheumatology
DOIs
Publication statusE-pub ahead of print - 1 Aug 2018

Fingerprint

Giant Cell Arteritis
MicroRNAs
Gene Expression
Arteries
Inflammation
Temporal Arteries
Systemic Vasculitis
Arteritis
Acute-Phase Reaction
Jaw
Scalp
Epigenomics
Headache
Pathologic Constriction
Extremities
Biomarkers
Biopsy

Cite this

Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies. / Kuret, Tadeja; Burja, Blaž; Feichtinger, Julia; Thallinger, Gerhard G; Frank-Bertoncelj, Mojca; Lakota, Katja; Žigon, Polona; Sodin-Semrl, Snezna; Čučnik, Saša; Tomšič, Matija; Hočevar, Alojzija.

In: Clinical Rheumatology, 01.08.2018.

Research output: Contribution to journalArticleResearchpeer-review

Kuret, T, Burja, B, Feichtinger, J, Thallinger, GG, Frank-Bertoncelj, M, Lakota, K, Žigon, P, Sodin-Semrl, S, Čučnik, S, Tomšič, M & Hočevar, A 2018, 'Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies' Clinical Rheumatology. https://doi.org/10.1007/s10067-018-4231-y
Kuret, Tadeja ; Burja, Blaž ; Feichtinger, Julia ; Thallinger, Gerhard G ; Frank-Bertoncelj, Mojca ; Lakota, Katja ; Žigon, Polona ; Sodin-Semrl, Snezna ; Čučnik, Saša ; Tomšič, Matija ; Hočevar, Alojzija. / Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies. In: Clinical Rheumatology. 2018.
@article{953bb72c8d3643468e5561ada254f376,
title = "Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies",
abstract = "Giant cell arteritis (GCA) is a systemic vasculitis in individuals older than 50 years, characterized by headaches, visual disturbances, painful scalp, jaw claudication, impairment of limb arteries, and systemic inflammation, among other symptoms. GCA diagnosis is confirmed by a positive temporal artery biopsy (TAB) or by imaging modalities. A prominent acute phase response with inflammation is the hallmark of the disease, predominantly targeting large- and medium-sized arteries leading to stenosis or occlusion of arterial lumen. To date, there are no reliable tissue markers specific for GCA. Scarce reports have indicated the importance of epigenetics in GCA. The current systematic review reports significantly changed candidate biomarkers in TABs of GCA patients compared to non-GCA patients using qPCR.",
author = "Tadeja Kuret and Blaž Burja and Julia Feichtinger and Thallinger, {Gerhard G} and Mojca Frank-Bertoncelj and Katja Lakota and Polona Žigon and Snezna Sodin-Semrl and Saša Čučnik and Matija Tomšič and Alojzija Hočevar",
year = "2018",
month = "8",
day = "1",
doi = "10.1007/s10067-018-4231-y",
language = "English",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer",

}

TY - JOUR

T1 - Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies

AU - Kuret, Tadeja

AU - Burja, Blaž

AU - Feichtinger, Julia

AU - Thallinger, Gerhard G

AU - Frank-Bertoncelj, Mojca

AU - Lakota, Katja

AU - Žigon, Polona

AU - Sodin-Semrl, Snezna

AU - Čučnik, Saša

AU - Tomšič, Matija

AU - Hočevar, Alojzija

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Giant cell arteritis (GCA) is a systemic vasculitis in individuals older than 50 years, characterized by headaches, visual disturbances, painful scalp, jaw claudication, impairment of limb arteries, and systemic inflammation, among other symptoms. GCA diagnosis is confirmed by a positive temporal artery biopsy (TAB) or by imaging modalities. A prominent acute phase response with inflammation is the hallmark of the disease, predominantly targeting large- and medium-sized arteries leading to stenosis or occlusion of arterial lumen. To date, there are no reliable tissue markers specific for GCA. Scarce reports have indicated the importance of epigenetics in GCA. The current systematic review reports significantly changed candidate biomarkers in TABs of GCA patients compared to non-GCA patients using qPCR.

AB - Giant cell arteritis (GCA) is a systemic vasculitis in individuals older than 50 years, characterized by headaches, visual disturbances, painful scalp, jaw claudication, impairment of limb arteries, and systemic inflammation, among other symptoms. GCA diagnosis is confirmed by a positive temporal artery biopsy (TAB) or by imaging modalities. A prominent acute phase response with inflammation is the hallmark of the disease, predominantly targeting large- and medium-sized arteries leading to stenosis or occlusion of arterial lumen. To date, there are no reliable tissue markers specific for GCA. Scarce reports have indicated the importance of epigenetics in GCA. The current systematic review reports significantly changed candidate biomarkers in TABs of GCA patients compared to non-GCA patients using qPCR.

U2 - 10.1007/s10067-018-4231-y

DO - 10.1007/s10067-018-4231-y

M3 - Article

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

ER -